Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul-Aug;27(4):351-6.
doi: 10.1016/j.jdiacomp.2012.12.006. Epub 2013 Jun 13.

Adapting and validating diabetes simulation models across settings: accounting for mortality differences using administrative data

Alison J Hayes  1 , Wendy A Davis, Timothy M Davis, Philip M Clarke
Affiliations

Adapting and validating diabetes simulation models across settings: accounting for mortality differences using administrative data

Alison J Hayes et al. J Diabetes Complications. 2013 Jul-Aug.

Abstract

Aims: To develop age and sex-specific risk equations for predicting mortality following major complications of diabetes, using a large linked administrative dataset from Western Australia (WA) and to incorporate these into an existing diabetes simulation model.

Methods: The study uses linked hospital and mortality records on 13,884 patients following a major diabetes-related complication with a mean (SD) duration of 2.62 (2.25) years. Risk equations for predicting mortality were derived and integrated into the UKPDS Outcomes Model. Estimates of life expectancy and incremental QALYs gained as a result of two theoretical therapies (a reduction of HbA1c of 1%, and reduction of systolic blood pressure of 10 mmHg) were determined using the original and adapted models.

Results: The two versions of the model generated differences in life expectancy following specific events; however there was little impact of using alternative mortality equations on incremental QALYs gained as a result of reducing HbA(1c) or systolic blood pressure, or on outcomes of life expectancy for a cohort initially free of complications.

Conclusions: Mortality following complications varies across diabetic populations and can impact on estimates of life expectancy, but appears to have less impact on incremental benefits of interventions that are commonly used in pharmoeconomic analyses.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comparison of survival following complications for 70–79 age group, with simulated survival from two different models. Shaded area= Kaplan Meier 95% confidence interval of observed WA survival; blue circles = simulation using UK death equations; brown circles = simulation using WA death equations.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Abbasi A, Corpeleijn E, Peelen LM, Gannsevoort RT, de Jong PE, Gans ROB, et al. External validation of the KORA S4/F4 prediction models for the risk of developing type 2 diabetes in older adults: the PREVEND study. European Journal of Epidemiology. 2012;27:47–52. - PubMed
    1. Altman DG, Vergouwe Y, Royston P, Moions KGM. Prognosis and prognostic research: validating a prognostic model. BMJ. 2009;338:b605. - PubMed
    1. American Diabetes Association Consensus Panel. Guidelines for Computer Modeling of Diabetes and its Complications. Diabetes Care. 2004;27:2262–2265. - PubMed
    1. Australian Institute of Health and Welfare. Diabetes series no. 17. Cat. no. CVD 56. Canberra: AIHW; 2011. Diabetes prevalence in Australia: detailed estimates for 2007–08. Viewed 3 December 2012 < http://www.aihw.gov.au/publication-detail/?id=10737419311>.
    1. D’Agostino RB, Sr, Grundy S, Sullivan LM, Wilson P CHD Risk Prediction Group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA. 2001;286(2):180–7. - PubMed

Publication types

  NODES
admin 4
Association 1
INTERN 2
twitter 2